Reported May 3, 2023 · Ongoing
Doxazosin Tablets, USP, 4mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN…
Northwind Pharmaceuticals LLC
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Northwind Pharmaceuticals LLC · 4838 Fletcher Ave Ste 1000 · Indianapolis, IN · 46203-1642
Is this the product you have?
- Doxazosin Tablets, USP, 4mg, 30-count bottles, Rx Only
- Repackaged ByNorthwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-109-52
- Lot codes and dates
Lot#: F107752201Exp. Date 05/31/2024
- Amount recalled
- 33 bottles
This recall covers 7 products
The agency filed one notice per product. You are reading one of them; the other 6 are below.
Where it was sold
- Nationwide
Why it was recalled
CGMP Deviations
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Northwind Pharmaceuticals LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.